Novadoz Pharmaceuticals, is the sales and marketing subsidiary for MSN Lab’s portfolio of finished dosage forms. MSN Labs is a global leader in the development & manufacturing of APIs (active pharmaceutical ingredients). The company is one of the leading holders of active DMFs (Drug Master Files) and supplies a majority of U.S based generic pharma companies with API. In addition to API, MSN develops and manufactures KSMs (key starting materials), and product intermediates which are the “building blocks” of API. Having vertical integration with API, as well as backward integration with KSMs, and intermediates has produced a highly efficient and successful manufacturing process for the organization. We currently market oral solids (tablets, capsules) as well as injectables, including oncology and specialty products.

MSN produces high quality generics with a concentrated focus on maintaining the highest cGMP standards. This has yielded a stellar track record in the U.S with the FDA, as well similar excellence in other regulated markets. The engine to our growth is rooted in the expertise of our R&D team. Our company’s commitment to developing and submitting API and finished dose generic products for FDA approval, has provided us with a deep and extensive product pipeline.

Novadoz maintains its core focus to be a consistent and reliable supplier of generics to its customers, while emerging as an industry leader with future product launches.

RECENT COMPANY UPDATES

Mission Statement

Novadoz Pharmaceuticals is committed to being a reliable and consistent supplier of safe, effective, and affordable generic pharmaceuticals. Our unwavering focus on quality, ensures that patients who take our medications will have access to a reliable and trusted manufacturing source.  We will continue to reinvest in  product R&D and manufacturing technology, introducing important generic and specialty products that benefit the entire pharmaceutical supply chain.  The foundation of our organization is built on principles of integrity, and the strength of the relationships we maintain with our employees and customers.

Novadoz Pharmaceuticals, is the sales and marketing subsidiary for MSN Lab’s portfolio of finished dosage forms. MSN Labs is a global leader in the development & manufacturing of APIs (active pharmaceutical ingredients). The company is one of the leading holders of active DMFs (Drug Master Files) and supplies a majority of U.S based generic pharma companies with API. In addition to API, MSN develops and manufactures KSMs (key starting materials), and product intermediates which are the “building blocks” of API. Having vertical integration with API, as well as backward integration with KSMs, and intermediates has produced a highly efficient and successful manufacturing process for the organization. We currently market oral solids (tablets, capsules) as well as injectables, including oncology and specialty products.

MSN produces high quality generics with a concentrated focus on maintaining the highest cGMP standards. This has yielded a stellar track record in the U.S with the FDA, as well similar excellence in other regulated markets. The engine to our growth is rooted in the expertise of our R&D team. Our company’s commitment to developing and submitting API and finished dose generic products for FDA approval, has provided us with a deep and extensive product pipeline.

Novadoz maintains its core focus to be a consistent and reliable supplier of generics to its customers, while emerging as an industry leader with future product launches.

MEET US AT

November 5th 2019
Frankfurt, Germany
MSN Labs Booth #61D10

 

Generic/Retail Pharmacy Event
February 26-29, 2020
Marriott New Orleans
New Orleans, LA

 

Follow Us on LinkedIn

linked-in icon